$19.87
1.608.76%
At close: -
$19.87
0.000.00%
After Hours: 4:24 PM EDT
Comments
Loading...
Dianthus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:DNTH | Benzinga
Dianthus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 11
EPS
$-0.810
Quarterly Revenue
$1.32M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$6.24M
Analyze the earnings history of Dianthus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNTH | Dianthus Therapeutics | -$0.54 | — | — | — | $874.00K | — | — | — | 05/08/2025 | Get Alert |
| DNTH | Dianthus Therapeutics | -$0.71 | -$0.85 | -$0.81 | 4.71% | $457.00K | $859.70K | $1.32M | 54.12% | 03/11/2025 | Get Alert |
| DNTH | Dianthus Therapeutics | -$3.78 | -$0.61 | -$0.74 | -21.31% | $924.00K | $600.00K | $2.17M | 262.00% | 11/07/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | -$12.73 | -$0.55 | -$0.51 | 7.27% | $969.00K | $322.75K | $1.86M | 477.23% | 08/08/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | -$8.10 | -$0.44 | -$0.54 | -22.73% | $476.00K | $460.00K | $874.00K | 90.00% | 05/09/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | — | -$1.01 | -$0.71 | 29.70% | — | $310.00K | $457.00K | 47.42% | 03/21/2024 | Get Alert |
| DNTH | Dianthus Therapeutics | -$8.90 | — | -$3.78 | — | $1.17M | — | $924.00K | — | 11/09/2023 | Get Alert |
Dianthus Therapeutics (DNTH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.81 | $-0.85 | 4.71 % |
| Q3 | 2024-11-07 | $-0.74 | $-0.61 | -21.3 % |
| Q2 | 2024-08-08 | $-0.51 | $-0.55 | 7.27 % |
| Q1 | 2024-05-09 | $-0.54 | $-0.44 | -22.7 % |
Dianthus Therapeutics (DNTH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $1.33M | $859.70K | 54.1 % |
| Q3 | 2024-11-07 | $2.17M | $600.00K | 262.0 % |
| Q2 | 2024-08-08 | $1.86M | $322.75K | 477.2 % |
| Q1 | 2024-05-09 | $874.00K | $460.00K | 90.0 % |
FAQ
When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?
Dianthus Therapeutics (DNTH) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Dianthus Therapeutics (NASDAQ:DNTH)?
The Actual EPS was $-0.81, which beat the estimate of $-0.85.
What were Dianthus Therapeutics’s (NASDAQ:DNTH) revenues?
The Actual Revenue was $1.3M, which beat the estimate of $859.7K.
Browse earnings estimates, EPS, and revenue on all stocks.